Astal Laboratories [ASTALLTD] vs V-Mart Retail [VMART] Detailed Stock Comparison

Astal Laboratories
BSE
Loading...

V-Mart Retail
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Astal Laboratories wins in 13 metrics, V-Mart Retail wins in 5 metrics, with 0 ties. Astal Laboratories appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Astal Laboratories | V-Mart Retail | Better |
---|---|---|---|
P/E Ratio (TTM) | 11.37 | 90.86 | Astal Laboratories |
Price-to-Book Ratio | 2.49 | 7.43 | Astal Laboratories |
Debt-to-Equity Ratio | 36.86 | 96.59 | Astal Laboratories |
PEG Ratio | N/A | 30.79 | N/A |
EV/EBITDA | 7.83 | 27.88 | Astal Laboratories |
Profit Margin (TTM) | 14.02% | 2.01% | Astal Laboratories |
Operating Margin (TTM) | 16.56% | 6.58% | Astal Laboratories |
EBITDA Margin (TTM) | 16.56% | 6.58% | Astal Laboratories |
Return on Equity | 30.09% | 5.65% | Astal Laboratories |
Return on Assets (TTM) | 17.86% | 1.88% | Astal Laboratories |
Free Cash Flow (TTM) | $-203.57M | $2.23B | V-Mart Retail |
1-Year Return | 1.78% | -17.11% | Astal Laboratories |
Price-to-Sales Ratio (TTM) | 1.41 | 1.83 | Astal Laboratories |
Enterprise Value | $1.01B | $67.43B | V-Mart Retail |
EV/Revenue Ratio | 1.59 | 2.01 | Astal Laboratories |
Gross Profit Margin (TTM) | 21.79% | 35.29% | V-Mart Retail |
Revenue per Share (TTM) | $65 | $423 | V-Mart Retail |
Earnings per Share (Diluted) | $8.04 | $8.37 | V-Mart Retail |
Beta (Stock Volatility) | -0.81 | 0.46 | Astal Laboratories |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Astal Laboratories vs V-Mart Retail Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Astal Laboratories | 1.92% | 8.74% | 13.24% | 15.51% | 7.21% | 21.02% |
V-Mart Retail | -1.27% | -2.54% | -3.22% | -9.90% | -12.72% | -21.74% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Astal Laboratories | 1.78% | 107.26% | 107.26% | 107.26% | 107.26% | 107.26% |
V-Mart Retail | -17.11% | 1.91% | 71.82% | 474.74% | 1,461.60% | 1,461.60% |
Performance & Financial Health Analysis: Astal Laboratories vs V-Mart Retail
Metric | ASTALLTD | VMART |
---|---|---|
Market Information | ||
Market Cap | ₹898.37M | ₹61.43B |
Market Cap Category | Small cap | Mid cap |
10 Day Avg. Volume | 24,421 | 124,059 |
90 Day Avg. Volume | 31,810 | 163,809 |
Last Close | ₹95.18 | ₹760.50 |
52 Week Range | ₹66.72 - ₹131.70 | ₹676.04 - ₹1,130.00 |
% from 52W High | -27.73% | -32.70% |
All-Time High | ₹131.70 (Sep 09, 2024) | ₹4,848.80 (Nov 08, 2021) |
% from All-Time High | -27.73% | -84.32% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.90% | 0.13% |
Quarterly Earnings Growth | 9.67% | 1.77% |
Financial Health | ||
Profit Margin (TTM) | 0.14% | 0.02% |
Operating Margin (TTM) | 0.17% | 0.07% |
Return on Equity (TTM) | 0.30% | 0.06% |
Debt to Equity (MRQ) | 36.86 | 96.59 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹36.75 | ₹102.30 |
Cash per Share (MRQ) | ₹1.77 | ₹7.84 |
Operating Cash Flow (TTM) | ₹-125,173,000 | ₹-317,500,000 |
Levered Free Cash Flow (TTM) | ₹89.25M | ₹457.70M |
Dividends | ||
Last 12-Month Dividend Yield | N/A | N/A |
Last 12-Month Dividend | N/A | ₹0.00 |
Valuation & Enterprise Metrics Analysis: Astal Laboratories vs V-Mart Retail
Metric | ASTALLTD | VMART |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 11.37 | 90.86 |
Forward P/E | N/A | 30.79 |
PEG Ratio | N/A | 30.79 |
Price to Sales (TTM) | 1.41 | 1.83 |
Price to Book (MRQ) | 2.49 | 7.43 |
Market Capitalization | ||
Market Capitalization | ₹898.37M | ₹61.43B |
Enterprise Value | ₹1.01B | ₹67.43B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 1.59 | 2.01 |
Enterprise to EBITDA | 7.83 | 27.88 |
Risk & Other Metrics | ||
Beta | -0.81 | 0.46 |
Book Value per Share (MRQ) | ₹36.75 | ₹102.30 |
Financial Statements Comparison: Astal Laboratories vs V-Mart Retail
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | ASTALLTD | VMART |
---|---|---|
Revenue/Sales | ₹234.67M | ₹8.85B |
Cost of Goods Sold | ₹183.53M | ₹5.73B |
Gross Profit | ₹51.14M | ₹3.12B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹40.79M | ₹582.50M |
EBITDA | ₹42.18M | ₹1.29B |
Pre-Tax Income | ₹38.49M | ₹429.40M |
Income Tax | ₹11.04M | ₹93.40M |
Net Income (Profit) | ₹27.45M | ₹336.00M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | ASTALLTD | VMART |
---|---|---|
Cash & Equivalents | ₹17.30M | ₹394.20M |
Total Current Assets | ₹456.39M | ₹12.26B |
Total Current Liabilities | ₹267.71M | ₹11.68B |
Long-Term Debt | ₹4.56M | ₹4.41B |
Total Shareholders Equity | ₹359.95M | ₹8.10B |
Retained Earnings | N/A | ₹2.75B |
Property, Plant & Equipment | N/A | ₹9.97B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | ASTALLTD | VMART |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | ASTALLTD | VMART |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 24,421 | 124,059 |
Average Daily Volume (90 Day) | 31,810 | 163,809 |
Shares Outstanding | 9.83M | 79.20M |
Float Shares | 3.37M | 36.73M |
% Held by Insiders | 0.57% | 0.52% |
% Held by Institutions | 0.00% | 0.37% |
Dividend Analysis & Yield Comparison: Astal Laboratories vs V-Mart Retail
Metric | ASTALLTD | VMART |
---|---|---|
Last 12-Month Dividend | N/A | ₹0.00 |
Last 12-Month Dividend Yield | N/A | N/A |
3-Year Avg Annual Dividend | N/A | ₹0.25 |
3-Year Avg Dividend Yield | N/A | 0.03% |
3-Year Total Dividends | N/A | ₹0.75 |
Ex-Dividend Date | N/A | Aug 18, 2022 |